Cargando…
Larotrectinib for solid tumours
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218391/ https://www.ncbi.nlm.nih.gov/pubmed/35755993 http://dx.doi.org/10.18773/austprescr.2022.035 |
_version_ | 1784731877512314880 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9218391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-92183912022-06-23 Larotrectinib for solid tumours Aust Prescr New Drugs NPS MedicineWise 2022-06-01 2022-06 /pmc/articles/PMC9218391/ /pubmed/35755993 http://dx.doi.org/10.18773/austprescr.2022.035 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | New Drugs Larotrectinib for solid tumours |
title | Larotrectinib for solid tumours |
title_full | Larotrectinib for solid tumours |
title_fullStr | Larotrectinib for solid tumours |
title_full_unstemmed | Larotrectinib for solid tumours |
title_short | Larotrectinib for solid tumours |
title_sort | larotrectinib for solid tumours |
topic | New Drugs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218391/ https://www.ncbi.nlm.nih.gov/pubmed/35755993 http://dx.doi.org/10.18773/austprescr.2022.035 |